Dr Barantsevich and colleagues describe a series of 49 trauma patients at an ICU in Moscow from whom Candida auris was isolated. Fluconazole resistance was widespread. However, no isolates were recovered by monthly swabbing of the hospital environment, healthcare workers’ hands and devices.
Recommendations for using anidulafungin (Ecalta/Eraxis) to treat invasive candidiasis in children are largely extrapolated from trials in adults. Dr Roilides and colleagues have published data from a trial of 49 children reporting a global response rate of 71% and a drug-related adverse event rate of 37% (10% discontinued due to AEs).